(Q38104756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Ankit Kumar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Umesh Kumar Singh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

Future Medicinal Chemistry

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

809-829

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine

29 February 2020

cites work

1 reference

Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

21 January 2018

1 reference

Honokiol, a multifunctional antiangiogenic and antitumor agent

21 January 2018

1 reference

The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production

21 January 2018

1 reference

An expedient synthesis of honokiol and its analogues as potential neuropreventive agents

21 January 2018

1 reference

Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship

21 January 2018

1 reference

Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation

21 January 2018

1 reference

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors

21 January 2018

1 reference

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function

21 January 2018

1 reference

The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells

21 January 2018

1 reference

Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells

21 January 2018

1 reference

Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity

21 January 2018

1 reference

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

21 January 2018

1 reference

Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2).

21 January 2018

1 reference

Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro

21 January 2018

1 reference

Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals

21 January 2018

1 reference

Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth

21 January 2018

1 reference

Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction

21 January 2018

1 reference

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

21 January 2018

1 reference

Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress

21 January 2018

1 reference

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

21 January 2018

1 reference

NF-kappaB functions in the nervous system: from development to disease

21 January 2018

1 reference

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription

21 January 2018

1 reference

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

21 January 2018

1 reference

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

21 January 2018

1 reference

Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.

21 January 2018

1 reference

The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

21 January 2018

1 reference

Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity

21 January 2018

1 reference

Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells

21 January 2018

1 reference

Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice

21 January 2018

1 reference

Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway

21 January 2018

1 reference

Targeting Phospholipase D-mediated Survival Signals in Cancer

21 January 2018

1 reference

Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells

21 January 2018

1 reference

Mitochondriotoxic compounds for cancer therapy

21 January 2018

1 reference

Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection

21 January 2018

1 reference

The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.

21 January 2018

1 reference

Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents

21 January 2018

1 reference

Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models

21 January 2018

1 reference

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

21 January 2018

1 reference

Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma

21 January 2018

1 reference

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells

21 January 2018

1 reference

Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model

21 January 2018

1 reference

Honokiol: a potent chemotherapy candidate for human colorectal carcinoma

21 January 2018

1 reference

Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells

21 January 2018

1 reference

Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model

21 January 2018

1 reference

Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells

21 January 2018

1 reference

Apoptosis induced by Magnolia Grandiﬂora extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells

21 January 2018

1 reference

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons

21 January 2018

1 reference

Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists

21 January 2018

1 reference

The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors

21 January 2018

1 reference

Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship

21 January 2018

1 reference

In vitro growth inhibition of human cancer cells by novel honokiol analogs

21 January 2018

1 reference

Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol

21 January 2018

1 reference

Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol

21 January 2018

1 reference

Cytotoxic neolignans: an SAR study.

21 January 2018

1 reference

Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.

21 January 2018

1 reference

Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production

21 January 2018

1 reference

Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity

21 January 2018

1 reference

Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents

21 January 2018

1 reference

Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells

21 January 2018

1 reference

Honokiol: a novel natural agent for cancer prevention and therapy

21 January 2018

1 reference

The Mitochondrial Permeability Transition Pore is Modulated by Oxidative Agents Through Both Pyridine Nucleotides and Glutathione at Two Separate Sites

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.13.32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23651094%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference